Mechanisms of Flavivirus Cross-Protection against Yellow Fever in a Mouse Model

被引:1
|
作者
Shinde, Divya P. [1 ,2 ]
Walker, Jordyn [1 ,2 ]
Reyna, Rachel A. [1 ,2 ]
Scharton, Dionna [1 ,2 ]
Mitchell, Brooke [1 ,2 ]
Dulaney, Ennid [1 ,2 ]
Bonam, Srinivisa Reddy [1 ]
Hu, Haitao [1 ]
Plante, Jessica A. [1 ,2 ]
Plante, Kenneth S. [1 ,2 ,3 ]
Weaver, Scott C. [1 ,2 ,3 ]
机构
[1] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA
[2] Univ Texas Med Branch, World Reference Ctr Emerging Viruses & Arboviruses, Galveston, TX 77555 USA
[3] Univ Texas Med Branch, Inst Human Infect & Immun, Galveston, TX 77555 USA
来源
VIRUSES-BASEL | 2024年 / 16卷 / 06期
基金
美国国家卫生研究院;
关键词
mosquito-borne viruses; cross-protection; mouse model; dengue; Zika; yellow fever virus; ZIKA VIRUS; TRANSMISSION; CHIKUNGUNYA; AMERICA; HISTORY;
D O I
10.3390/v16060836
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The complete lack of yellow fever virus (YFV) in Asia, and the lack of urban YFV transmission in South America, despite the abundance of the peridomestic mosquito vector Aedes (Stegomyia.) aegypti is an enigma. An immunologically na & iuml;ve population of over 2 billion resides in Asia, with most regions infested with the urban YF vector. One hypothesis for the lack of Asian YF, and absence of urban YF in the Americas for over 80 years, is that prior immunity to related flaviviruses like dengue (DENV) or Zika virus (ZIKV) modulates YFV infection and transmission dynamics. Here we utilized an interferon alpha/beta receptor knock-out mouse model to determine the role of pre-existing dengue-2 (DENV-2) and Zika virus (ZIKV) immunity in YF virus infection, and to determine mechanisms of cross-protection. We utilized African and Brazilian YF strains and found that DENV-2 and ZIKV immunity significantly suppresses YFV viremia in mice, but may or may not protect relative to disease outcomes. Cross-protection appears to be mediated mainly by humoral immune responses. These studies underscore the importance of re-assessing the risks associated with YF outbreak while accounting for prior immunity from flaviviruses that are endemic.
引用
收藏
页数:17
相关论文
共 50 条
  • [21] Vaccine approaches conferring cross-protection against influenza viruses
    Vemula, Sai V.
    Sayedahmed, Ekramy E.
    Sambhara, Suryaprakash
    Mittal, Suresh K.
    EXPERT REVIEW OF VACCINES, 2017, 16 (11) : 1141 - 1154
  • [22] CROSS-PROTECTION STUDIES WITH YELLOW-VEIN AND CERTAIN OTHER VIRUSES OF CITRUS
    WEATHERS, LG
    PHYTOPATHOLOGY, 1958, 48 (08) : 399 - 399
  • [23] A meningococcal B vaccine induces cross-protection against gonorrhea
    Ochoa Azze, Rolando Felipe
    CLINICAL AND EXPERIMENTAL VACCINE RESEARCH, 2019, 8 (02) : 110 - 115
  • [24] CROSS-PROTECTION EXPERIMENTS AGAINST APRICOT CHLOROTIC LEAF ROLL
    MORVAN, G
    AGRONOMIE, 1982, 2 (08): : 785 - 786
  • [25] Dengue virus envelope protein domain III-elicited antibodies mediate cross-protection against Zika virus in a mouse model
    Zhou, Yongchao
    Chen, Dong
    Yang, Lan
    Zou, Weiwei
    Duan, Zhiliang
    Zhang, Yanjun
    Wen, Jinsheng
    VIRUS RESEARCH, 2020, 278
  • [26] Cross-protection in influenza: Tachypnea as a measure of protection in the cotton rat model
    Straight, TM
    Eichelberger, M
    Ottolini, MG
    PEDIATRIC RESEARCH, 2004, 55 (04) : 333A - 333A
  • [27] Cross-Protection Against Bean yellow mosaic virus (BYMV) and Clover yellow vein virus by Attenuated BYMV Isolate M11
    Nakazono-Nagaoka, Eiko
    Takahashi, Tsubasa
    Shimizu, Takumi
    Kosaka, Yoshitaka
    Natsuaki, Tomohide
    Omura, Toshihiro
    Sasaya, Takahide
    PHYTOPATHOLOGY, 2009, 99 (03) : 251 - 257
  • [28] Arthritogenic Alphavirus Vaccines: Serogrouping Versus Cross-Protection in Mouse Models
    Nguyen, Wilson
    Nakayama, Eri
    Yan, Kexin
    Tang, Bing
    Le, Thuy T.
    Liu, Liang
    Cooper, Tamara H.
    Hayball, John D.
    Faddy, Helen M.
    Warrilow, David
    Allcock, Richard J. N.
    Hobson-Peters, Jody
    Hall, Roy A.
    Rawle, Daniel J.
    Lutzky, Viviana P.
    Young, Paul
    Oliveira, Nidia M.
    Hartel, Gunter
    Howley, Paul M.
    Prow, Natalie A.
    Suhrbier, Andreas
    VACCINES, 2020, 8 (02)
  • [29] A mechanism for BCG vaccine cross-protection against pulmonary viral infections
    Tran, Kim A.
    Divangahi, Maziar
    NATURE IMMUNOLOGY, 2024, 25 (03) : 403 - 404
  • [30] Population dynamics of cross-protection against β-lactam antibiotics in droplet microreactors
    Zhao, Xinne
    Ruelens, Philip
    Farr, Andrew D.
    de Visser, J. Arjan G. M.
    Baraban, Larysa
    FRONTIERS IN MICROBIOLOGY, 2023, 14